[1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoicacid (BioDeep_00000175477)
human metabolite blood metabolite
代谢物信息卡片
[1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoicacid
化学式: C21H29N3O4 (387.21579540000005)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: OC(=O)CCCC=CCC1C2CCC(O2)C1CNNC(=O)NC1=CC=CC=C1
InChI: InChI=1S/C21H29N3O4/c25-20(26)11-7-2-1-6-10-16-17(19-13-12-18(16)28-19)14-22-24-21(27)23-15-8-4-3-5-9-15/h1,3-6,8-9,16-19,22H,2,7,10-14H2,(H,25,26)(H2,23,24,27)
描述信息
同义名列表
5 个代谢物同义名
[1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoicacid; [1S-[1a,2a(Z),3a,4a]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoicacid; [1S-[1Α,2α(Z),3α,4α]]-7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoicacid; 7-[3-({[(phenyl-C-hydroxycarbonimidoyl)amino]amino}methyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoate; 7-[3-({[(phenylcarbamoyl)amino]amino}methyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Huanjun Xu, Hong Lu, Xiaocui Zhu, Wei Wang, Zhoumiao Zhang, Huizheng Fu, Shuangcheng Ma, Yuehua Luo, Jianjiang Fu. Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro.
International journal of molecular medicine.
2018 Jul; 42(1):615-624. doi:
10.3892/ijmm.2018.3634. [PMID: 29693158] - Ralf A Benndorf, Edzard Schwedhelm, Anke Gnann, Raihana Taheri, Ghainsom Kom, Michael Didié, Anna Steenpass, Süleyman Ergün, Rainer H Böger. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Circulation research.
2008 Oct; 103(9):1037-46. doi:
10.1161/circresaha.108.184036. [PMID: 18802021] - S Rolin, J Hanson, C Vastersaegher, C Cherdon, D Pratico, B Masereel, J M Dogne. BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alphain vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents.
Prostaglandins & other lipid mediators.
2007 Aug; 84(1-2):14-23. doi:
10.1016/j.prostaglandins.2007.03.002. [PMID: 17643884] - Masaya Iwashita, Masaki Saito, Yasunaga Yamaguchi, Ryoji Takagaki, Norimichi Nakahata. Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor.
Biological & pharmaceutical bulletin.
2007 Jul; 30(7):1221-5. doi:
10.1248/bpb.30.1221. [PMID: 17603157] - Zhong Jian Cheng, Yan-Fen Jiang, Hong Ding, David Severson, Chris R Triggle. Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products.
Canadian journal of physiology and pharmacology.
2007 Mar; 85(3-4):404-12. doi:
10.1139/y07-010. [PMID: 17612649] - Myan Tang, Tillmann Cyrus, Yuemang Yao, Luigina Vocun, Domenico Praticò. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice.
Circulation.
2005 Nov; 112(18):2867-74. doi:
10.1161/circulationaha105.562223. [PMID: 16267259] - Anila Kumar, Edward Kingdon, Jill Norman. The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
2005 Mar; 19(3):443-5. doi:
10.1096/fj.03-1364fje. [PMID: 15640282] - Sarah J O'Meara, B Therese Kinsella. Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.
British journal of pharmacology.
2004 Sep; 143(2):292-302. doi:
10.1038/sj.bjp.0705947. [PMID: 15326037] - François Valentin, Mark C Field, John R Tippins. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells.
The Journal of biological chemistry.
2004 Feb; 279(9):8316-24. doi:
10.1074/jbc.m306761200. [PMID: 14583632] - Frances Moore, Gergely Asbóth, Bernal Andrés López. Thromboxane receptor signalling in human myometrial cells.
Prostaglandins & other lipid mediators.
2002 Jan; 67(1):31-47. doi:
10.1016/s0090-6980(01)00169-1. [PMID: 11789896] - M Y Abeywardena, R J Head. Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat.
Prostaglandins, leukotrienes, and essential fatty acids.
2001 Aug; 65(2):91-7. doi:
10.1054/plef.2001.0294. [PMID: 11545625] - G Stephens, N O'Luanaigh, D Reilly, P Harriott, B Walker, D Fitzgerald, N Moran. A sequence within the cytoplasmic tail of GpIIb independently activates platelet aggregation and thromboxane synthesis.
The Journal of biological chemistry.
1998 Aug; 273(32):20317-22. doi:
10.1074/jbc.273.32.20317. [PMID: 9685382] - J Kunes, M M Mazeaud, M A Devynck, J Zicha. Platelet hypoaggregability in hereditary hypertriglyceridemic rats: relation to plasma triglycerides.
Thrombosis research.
1997 Nov; 88(4):347-53. doi:
10.1016/s0049-3848(97)00264-8. [PMID: 9526957] - C Calzada, E Vericel, M Lagarde. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
The Biochemical journal.
1997 Jul; 325 ( Pt 2)(?):495-500. doi:
10.1042/bj3250495. [PMID: 9230133] - J Möbert, B F Becker, S Zahler, E Gerlach. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts.
Journal of cardiovascular pharmacology.
1997 Jun; 29(6):789-94. doi:
10.1097/00005344-199706000-00012. [PMID: 9234660] - R Marley, D Harry, R Anand, B Fernando, S Davies, K Moore. 8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats.
Gastroenterology.
1997 Jan; 112(1):208-13. doi:
10.1016/s0016-5085(97)70237-3. [PMID: 8978361] - S T Davidge, C A Hubel, M K McLaughlin. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats.
The American journal of physiology.
1996 Dec; 271(6 Pt 2):R1625-31. doi:
10.1152/ajpregu.1996.271.6.r1625. [PMID: 8997362] - E R Mohler, M T Franklin, L P Adam. Intracellular signaling by 8-epi-prostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries.
Biochemical and biophysical research communications.
1996 Aug; 225(3):915-23. doi:
10.1006/bbrc.1996.1272. [PMID: 8780711] - H Suzuki, X P Gao, C O Olopade, H A Jaffe, S Pakhlevaniants, I Rubinstein. Aqueous smokeless tobacco extract impairs endothelium-dependent vasodilation in the oral mucosa.
Journal of applied physiology (Bethesda, Md. : 1985).
1996 Jul; 81(1):225-31. doi:
10.1152/jappl.1996.81.1.225. [PMID: 8828668] - G Cirino, R Sorrentino, C Cicala, L Sorrentino, A Pinto. Indomethacin and thromboxane A2/prostaglandin H2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats.
Journal of lipid mediators and cell signalling.
1996 Mar; 13(2):177-87. doi:
10.1016/0929-7855(95)00051-8. [PMID: 8925198] - Y Bayon, M Croset, D Daveloose, F Guerbette, V Chirouze, J Viret, J C Kader, M Lagarde. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
Journal of lipid research.
1995 Jan; 36(1):47-56. doi:
. [PMID: 7706947] - S T Davidge, C A Hubel, M K McLaughlin. Lipid peroxidation increases arterial cyclooxygenase activity during pregnancy.
American journal of obstetrics and gynecology.
1994 Jan; 170(1 Pt 1):215-22. doi:
10.1016/s0002-9378(94)70410-4. [PMID: 8296825] - S T Davidge, C A Hubel, M K McLaughlin. Cyclooxygenase-dependent vasoconstrictor alters vascular function in the vitamin E-deprived rat.
Circulation research.
1993 Jul; 73(1):79-88. doi:
10.1161/01.res.73.1.79. [PMID: 8508535] - E A Lianos, B B Bresnahan, S Wu. Pathophysiologic role of eicosanoids in mesangial cell immune injury.
Journal of lipid mediators.
1993 Mar; 6(1-3):333-42. doi:
". [PMID: 8357992] - K Takahashi, T M Nammour, M Fukunaga, J Ebert, J D Morrow, L J Roberts, R L Hoover, K F Badr. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
The Journal of clinical investigation.
1992 Jul; 90(1):136-41. doi:
10.1172/jci115826. [PMID: 1386085] - C Hammerman, M J Aramburo, V Hill. Intravenous lipids in newborn lungs: thromboxane-mediated effects.
Critical care medicine.
1989 May; 17(5):430-6. doi:
10.1097/00003246-198905000-00011. [PMID: 2707013] - L M Bradley, G Feuerstein, R E Goldstein. The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns.
Progress in clinical and biological research.
1989; 301(?):247-52. doi:
". [PMID: 2798449] - L M Bradley, R E Goldstein, G Feuerstein, J F Czaja. Circulatory effects of PAF-acether in newborn piglets.
The American journal of physiology.
1989 Jan; 256(1 Pt 2):H205-12. doi:
10.1152/ajpheart.1989.256.1.h205. [PMID: 2912183]